(Q45868383)

17 December 2017

title

The special case of gene therapy pricing (English)

1 reference

17 December 2017

0 references

1

Troyen A Brennan

1 reference

17 December 2017

James Wilson

series ordinal

2

object named as

James M Wilson

1 reference

17 December 2017

publication date

1 September 2014

1 reference

17 December 2017

published in

Nature Biotechnology

1 reference

17 December 2017

volume

32

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

874-876

1 reference

17 December 2017

Gene therapy through autologous transplantation of gene-modified hematopoietic stem cells

cites work

1 reference

Safety and efficacy of gene transfer for Leber's congenital amaurosis

21 January 2018

1 reference

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B

21 January 2018

1 reference

Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer

21 January 2018

1 reference

Lessons learned from the clinical development and market authorization of Glybera.

21 January 2018

1 reference

An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.

21 January 2018

1 reference

Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases

21 January 2018

1 reference

Vaccine advance-purchase agreements for low-income countries: practical issues.

21 January 2018

1 reference

New Expensive Treatments for Hepatitis C Infection

21 January 2018

1 reference

Recombinant adeno-associated virus: clinical application and development as a gene-therapy vector.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25203033

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NBT.3003

1 reference

17 December 2017

Dimensions Publication ID

1004085801

0 references

1 reference

17 December 2017